PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.580.04 (-0.71%)
5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.59%
Positive revenue growth while UPM.HE is negative. John Neff might see a notable competitive edge here.
179.92%
Positive gross profit growth while UPM.HE is negative. John Neff would see a clear operational edge over the competitor.
42.16%
EBIT growth similar to UPM.HE's 42.54%. Walter Schloss might infer both firms share similar operational efficiencies.
42.16%
Operating income growth similar to UPM.HE's 42.54%. Walter Schloss would assume both share comparable operational structures.
-20.26%
Negative net income growth while UPM.HE stands at 436.11%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-21.30%
Negative EPS growth while UPM.HE is at 429.41%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-21.30%
Negative diluted EPS growth while UPM.HE is at 429.41%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
1.35%
Share change of 1.35% while UPM.HE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
1.35%
Diluted share change of 1.35% while UPM.HE is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
-157.58%
Negative OCF growth while UPM.HE is at 0.76%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-329.13%
Negative FCF growth while UPM.HE is at 14.62%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-26.92%
Negative 10Y revenue/share CAGR while UPM.HE stands at 0.21%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-26.92%
Negative 5Y CAGR while UPM.HE stands at 31.19%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-29.81%
Negative 3Y CAGR while UPM.HE stands at 3.41%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-146.57%
Negative 10Y OCF/share CAGR while UPM.HE stands at 1045.92%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-146.57%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-152.08%
Negative 3Y OCF/share CAGR while UPM.HE stands at 56.17%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
119.59%
Below 50% of UPM.HE's 291.87%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
119.59%
5Y net income/share CAGR at 50-75% of UPM.HE's 219.95%. Martin Whitman might see a shortfall in operational efficiency or brand power.
-15.03%
Negative 3Y CAGR while UPM.HE is 12.14%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-19.10%
Negative 3Y equity/share growth while UPM.HE is at 2.30%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
76.91%
AR growth well above UPM.HE's 45.85%. Michael Burry fears inflated revenue or higher default risk in the near future.
6.35%
Inventory growth well above UPM.HE's 6.37%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
0.42%
Asset growth well under 50% of UPM.HE's 1.45%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-0.00%
We have a declining book value while UPM.HE shows 0.85%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
2.74%
Debt growth far above UPM.HE's 3.99%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
0.85%
We expand SG&A while UPM.HE cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.